Cacti is a biotech company advancing FDA approved, first-in-class "Nociplastigens" to treat chronic pain, inflammation, and opioid use disorder. Our interdisciplinary team aims to understand the psychological drivers of pain and bring transformative therapies to the patients at the heart of our mission.
| Website | https://www.cactitherapeutics.com |
| Employees | 26 (1 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Pain Management, Chronic Pain Treatment, Biotechnology, Inflammation Treatment, Opioid Use Disorder Treatment, Novel Therapeutics, Neuropathic Pain, Pain Relief, Analgesics, Drug Development, Pharmaceutical Research, Therapeutics, Clinical Trials, Bioscience, Innovative Medicines, Transformative Treatments |
| Competitors | Pfizer, Bristol Myers Squibb, Gilead Sciences, Madrigal Pharmaceuticals, Intercept Pharmaceuticals, Galapagos, Viking Therapeutics, Inc., Lilly India, Kadmon, a Sanofi Company, Hepion Pharmaceuticals +44 more (view full list) |
Looking for a particular Cacti employee's phone or email?
1 people are employed at Cacti.
Cacti is based in Dallas, Texas.